Orfo Fuel Capsules – 6.25mg
Orforglipron 6mg SLU-PP-33 25mcg This unique combination features Orforglipron, a non-peptide GLP-1 receptor agonist studied for its potential role in supporting metabolic function, paired with SLU-PP-332, a compound explored for its influence on energy metabolism and cellular performance. Together, they are being researched for their complementary effects on metabolic efficiency and energy regulation.
$300.00 / month
Orfo Fuel is a research compound blend combining Orforglipron and SLU-PP-332, studied in laboratory research for its interaction with metabolic-signaling and cellular-energy pathways. Advanced Peptide Institute supplies Orfo Fuel Capsules for laboratory research use only, at 99% purity and third-party tested for every batch.
What is Orfo Fuel?
Orfo Fuel is a two-compound research formulation pairing Orforglipron, a non-peptide small-molecule GLP-1 receptor agonist, with SLU-PP-332, a synthetic ERR (estrogen-related receptor) agonist studied in cellular-metabolism research. Orforglipron is studied in laboratory research for its interaction with the GLP-1 receptor, a G-protein-coupled receptor implicated in glucose-signaling and appetite-related hormone pathways. SLU-PP-332 is studied for its interaction with ERR-alpha/beta/gamma nuclear receptors, which are examined in research on mitochondrial biogenesis and cellular-energy-pathway signaling. Combining a GLP-1-receptor research agonist with an ERR-pathway research agonist allows researchers to examine potential cross-pathway relationships between incretin-receptor signaling and mitochondrial-energy-pathway signaling within a single standardized capsule format. Advanced Peptide Institute’s Orfo Fuel Capsules are supplied strictly for laboratory research use, at 99% purity with independent verification.
Research Applications
Orfo Fuel’s component compounds support several laboratory research applications. Orforglipron is studied in in vitro GLP-1 receptor-binding assays and cell-signaling models examining downstream cyclic-AMP pathway activity. SLU-PP-332 is examined in cell-culture models of ERR nuclear-receptor activation and its relationship to mitochondrial-biogenesis gene expression. Researchers studying metabolic-signaling pathways use both compounds as reference agonists in comparative receptor-pharmacology studies, including dose-response and receptor-selectivity assays. Additional research contexts include in vitro models examining how incretin-receptor signaling and nuclear-receptor-mediated mitochondrial pathways may interact at the cellular level, supporting multi-target metabolic-research protocols in approved laboratory settings.
Purity & Third-Party Testing
Every batch of Advanced Peptide Institute Orfo Fuel Capsules is manufactured to 99% purity and independently verified using HPLC (high-performance liquid chromatography) and mass spectrometry. These orthogonal testing methods confirm both compound identity and purity level prior to release. A batch-specific Certificate of Analysis is available for every lot at https://advancedpeptideinstitute.com/certificate-of-analysis/.
Storage & Handling
Store Orfo Fuel Capsules in a cool, dry place away from direct sunlight and moisture, in their original sealed packaging. Keep out of reach of children. This product is intended strictly for laboratory research use.
Frequently Asked Questions
What purity is Advanced Peptide Institute Orfo Fuel Capsules?
Advanced Peptide Institute Orfo Fuel Capsules is supplied at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. A Certificate of Analysis is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/.
How should Orfo Fuel Capsules be stored?
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
What is Orfo Fuel studied for in laboratory research?
Orfo Fuel is studied in laboratory research for its interaction with metabolic-signaling pathways, combining Orforglipron and SLU-PP-332 research compounds.
Published laboratory research on Orforglipron and SLU-PP-332 is indexed on PubMed.
Related Research Compounds: Limitless Capsules • BPC-157 Capsules – 500mcg • Browse all Capsules research compounds • Certificate of Analysis
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.